Ittichaicharoen, J., Phrommintikul, A., Chattipakorn, N., & Chattipakorn, S. (2018). Reduced salivary amylase activity in metabolic syndrome patients with obesity could be improved by treatment with a dipeptidyl peptidase IV inhibitor.
Chicago Style CitationIttichaicharoen, Jitjiroj, Arintaya Phrommintikul, Nipon Chattipakorn, and Siriporn Chattipakorn. Reduced Salivary Amylase Activity in Metabolic Syndrome Patients With Obesity Could Be Improved By Treatment With a Dipeptidyl Peptidase IV Inhibitor. 2018.
MLA引文Ittichaicharoen, Jitjiroj, Arintaya Phrommintikul, Nipon Chattipakorn, and Siriporn Chattipakorn. Reduced Salivary Amylase Activity in Metabolic Syndrome Patients With Obesity Could Be Improved By Treatment With a Dipeptidyl Peptidase IV Inhibitor. 2018.